← Open Payments lookup

ANITA KHANDELWAL: Open Payments

NPI 1518988047 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$886 in 28 payments from 11 companies in 2025. Trend: 2023 $1,068 · 2024 $1,221 · 2025 $886

Food & beverage: $886
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP12$341
Madrigal Pharmaceuticals1$120
GENZYME CORPORATION1$120
Lilly USA, LLC3$64
Novo Nordisk Inc3$61
GlaxoSmithKline, LLC.2$45
PFIZER INC.2$43
Sumitomo Pharma America, Inc.1$26
Ardelyx, Inc.1$24
Seqirus USA Inc1$22

Products named: AIRSUPRA, REZDIFFRA, DUPIXENT, BREZTRI, TRELEGY ELLIPTA, MOUNJARO, JARDIANCE, GEMTESA.

Industry payments across MD — which companies pay providers there.